Publication | Open Access

Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

ObesityMetabolic SyndromeDiabetes ManagementInsulin ManagementDiabetesType 2Obesity ManagementDiabetes MellitusMedicine